[HTML][HTML] Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric Aβ and tau species

XQ Chen, WC Mobley - Frontiers in Neuroscience, 2019 - frontiersin.org
Alzheimer disease (AD) represents an oncoming epidemic that without an effective
treatment promises to exact extraordinary human and financial burdens. Studies of …

[HTML][HTML] Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease

R Dhapola, SS Hota, P Sarma, A Bhattacharyya… - …, 2021 - Springer
Alzheimer's disease (AD) is a major contributor of dementia leading to the degeneration of
neurons in the brain with major symptoms like loss of memory and learning. Many evidences …

Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

X Xiang, K Wind, T Wiedemann, T Blume… - Science translational …, 2021 - science.org
2-Deoxy-2-[18F] fluoro-d-glucose positron emission tomography (FDG-PET) is widely used
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …

[PDF][PDF] Distinct molecular profiles of skull bone marrow in health and neurological disorders

ZI Kolabas, LB Kuemmerle, R Perneczky, B Förstera… - Cell, 2023 - cell.com
The bone marrow in the skull is important for shaping immune responses in the brain and
meninges, but its molecular makeup among bones and relevance in human diseases …

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation

M Ewers, G Biechele, M Suárez‐Calvet… - EMBO molecular …, 2020 - embopress.org
Microglia activation is the brain's major immune response to amyloid plaques in Alzheimer's
disease (AD). Both cerebrospinal fluid (CSF) levels of soluble TREM2 (sTREM2), a …

Opposite microglial activation stages upon loss of PGRN or TREM 2 result in reduced cerebral glucose metabolism

JK Götzl, M Brendel, G Werner, S Parhizkar… - EMBO molecular …, 2019 - embopress.org
Microglia adopt numerous fates with homeostatic microglia (HM) and a microglial
neurodegenerative phenotype (MG nD) representing two opposite ends. A number of …

[HTML][HTML] TSPO imaging in animal models of brain diseases

N Van Camp, S Lavisse, P Roost, F Gubinelli… - European Journal of …, 2021 - Springer
Over the last 30 years, the 18-kDa TSPO protein has been considered as the PET imaging
biomarker of reference to measure increased neuroinflammation. Generally assumed to …

[HTML][HTML] Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative …

AM Chaney, FR Lopez-Picon, S Serrière, R Wang… - Theranostics, 2021 - ncbi.nlm.nih.gov
Mouse models of Alzheimer's disease (AD) are valuable but do not fully recapitulate human
AD pathology, such as spontaneous Tau fibril accumulation and neuronal loss …

[HTML][HTML] Beta-amyloid imaging with florbetaben

O Sabri, J Seibyl, C Rowe, H Barthel - Clinical and translational imaging, 2015 - Springer
Abstract Florbetaben is a fluorine-18 (18 F)-labeled stilbene derivative that was developed
as a positron emission tomography (PET) tracer for routine clinical application to visualize β …

[HTML][HTML] Aβ plaques

LC Walker - Free neuropathology, 2020 - ncbi.nlm.nih.gov
Aβ plaques are one of the two lesions in the brain that define the neuropathological
diagnosis of Alzheimer's disease. Plaques are highly diverse structures; many of them …